The Fragile X Syndrome: From Molecular Genetics to Neurobiology

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 10, Issue 1, 2004, Pages 60-67

  Willemsen, Rob ^a   Oostra, Ben A ^a   Bassell, Gary J ^b   Dictenberg, Jason ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Dendritic mRNAs; FMRP; Fragile X syndrome; Mental retardation; Neurobiology; Synaptic plasticity

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; GENE PRODUCT;

FMR1 GENE; FRAGILE X SYNDROME; GENE; LEARNING; MEMORY; MOLECULAR GENETICS; MOLECULAR MECHANICS; NERVE CELL; NERVE CELL PLASTICITY; NEUROBIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; RNA TRANSLATION; RNA TRANSPORT; TRANSLATION REGULATION;

ANIMALS; DENDRITES; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MALE; MICE; MOLECULAR BIOLOGY; NERVE TISSUE PROTEINS; NEUROBIOLOGY; NEURONAL PLASTICITY; RNA-BINDING PROTEINS; SYNAPSES;

EID: 1642394283     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrdd.20010     Document Type: Review

References (102)

1. Aakalu G, Smith WB, Nguyen N, et al. 2001. Dynamic visualization of local protein synthesis in hippocampal neurons. Neuron 30:489-502.
2. Ainger K, Avossa D, Morgan F, et al. 1993. Transport and localization of exogenous myelin basic protein mRNA microinjected into oligodendrocytes. J Cell Biol 123:431-441.
3. Arai Y, Ijuin T, Takenawa T, et al. 2002. Excessive expression of synaptojanin in brains with Down syndrome. Brain Dev 24:67-72.
4. Ashley C, Jr., Wilkinson KD, Reines D, et al. 1993. FMR1 protein: Conserved RNP family domains and selective RNA binding. Science 262:563-568.
5. Bakker CE, de Diego Otero Y, Bontekoe C, et al. 2000. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res 258:162-170.
6. Bardoni B, Schenck A, Mandel JL. 1999. A novel RNA-binding nuclear protein that interacts with the Fragile X mental retardation (FMR1) protein. Hum Mol Genet 8:2557-2566.
7. Bardoni B, Willemsen R, Weiler I, et al. 2003. NUFIP1 (NUclear FMRP Interacting Protein 1) is a nucleo-cytoplasmic shuttling protein associated with active synaptoneurosomes. Exp Cell Res 289(1):95-107
8. Bassell GJ, Oleynikov Y, Singer RH. 1999. The travels of mRNAs through all cells large and small. FASEB J 13:447-454.
9. Bertrand E, Chartrand P, Schaefer M, et al. 1998. Localization of ASH1 mRNA particles in living yeast. Mol Cell 2:437-445.
10. Blichenberg A, Schwanke B, Rehbein M, et al. 1999. Identification of a cis-acting dendritic targeting element in MAP2 mRNAs. J Neurosci 19:8818-8829.
11. Bohl F, Kruse C, Frank A, et al. 2000. She2p, a novel RNA-binding protein tethers ASH1 mRNA to the Myo4p myosin motor via She3p. EMBO J 19:5514-5524.
12. Brown V, Small K, Lakkis L, et al. 1998. Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J Biol Chem 273:15521-15527.
13. Brown V, Jin P, Ceman S, et al. 2001. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107:477-487.
14. Burgin KE, Waxham MN, Rickling S, et al. 1990. In situ hybridization histochemistry of Ca2+/calmodulin-dependent protein kinase in developing rat brain. J Neurosci 10:1788-1798.
15. Carson JH, Kwon S, Barbarese E. 1998. RNA trafficking in myelinating cells. Curr Opin Neurobiol 8:607-612.
16. Castren M, Lampinen KE, Miettinen R, et al. 2002. BDNF regulates the expression of fragile x mental retardation protein mRNA in the hippocampus. Neurobiol Dis 11:221-229.
17. Caudy AA, Myers M, Hannon GJ, et al. 2002. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 16:2491-2496.
18. Ceman S, Brown V, Warren ST. 1999. Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol Cell Biol 19:7925-7932.
19. Ceman S, Nelson R, Warren ST. 2000. Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP particle. Biochem Biophys Res Commun 279:904-908.
20. Chartrand P, Meng XH, Huttelmaier S, et al. 2002. Asymmetric sorting of ash1p in yeast results from inhibition of translation by localization elements in the mRNA. Mol Cell 10:1319-1330.
21. Clark IE, Wyckoff D, Gavis ER. 2000. Synthesis of the posterior determinant Nanos is spatially restricted by a novel cotranslational regulatory mechanism. Curr Biol 10:1311-1314.
22. Comery TA, Harris JB, Willems PJ, et al. 1997. Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proc Natl Acad Sci USA 94:5401-5404.
23. Crino PB, Eberwine J. 1996. Molecular characterization of the dendritic growth cone: regulated mRNA transport and local protein synthesis. Neuron 17:1173-1187.
24. Darnell JC, Jensen KB, Jin P, et al. 2001. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107:489-499.
25. Dhanrajan TM, Oleynikov Y, Kelic S, et al. 2003. Activity-dependent trafficking and dynamic localization of ZBP1 and β-actin mRNA in dendrites and spines of hippocampal neurons. J Neurosci (in press).
26. De Boulle K, Verkerk AJ, Reyniers E, et al. 1993. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet 3:31-35.
27. De Diego Otero Y, Severijnen LA, Van Cappellen G, et al. 2002. Transport of fragile X ment retard protein via granules in neurites of PC12 Cells. Mol Cell Biol 22:8332-8341.
28. De Diego Otero Y, Bakker CE, Raghoe P, et al. 2000. Immunocytochemical characterization of FMRP, FXR1P and FXR2P during embryonic development in the mouse. Gene Funct Dis 1:28-37.
29. Devys D, Lutz Y, Rouyer N, et al. 1993. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
30. Didier DK, Schiffenbauer J, Woulfe SL, et al. 1988. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci USA 85:7322-7326.
31. Eberhart DE, Malter HE, Feng Y, et al. 1996. The fragile X mental retardation protein is a ribosonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 5:1083-1091.
32. Eberwine J, Belt B, Kacharmina JE, et al. 2002. Analysis of subcellularly localized mRNAs using in situ hybridization, mRNA amplification, and expression profiling. Neurochem Res 27:1065-1077.
33. Feng Y, Gutekunst CA, Eberhart DE, et al. 1997a. Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17:1539-1547.
34. Feng Y, Absher D, Eberhart DE, et al. 1997b FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell 1:109-118.
35. Fridell RA, Benson RE, Hua J, et al. 1996. A nuclear role for the fragile X mental retardation protein. EMBO J 15:5408-5414.
36. Garner CC, Tucker RP, Matus A. 1988. Selective localization of messenger RNA for cytoskeletal protein MAP2 in dendrites. Nature 336:674-677.
37. Gazzaley AH, Benson DL, Huntley GW, et al. 1997. Differential subcellular regulation of NMDAR1 protein and mRNA in dendrites of dentate gyrus granule cells after perforant path transection. J Neurosci 17:2006-2017.
38. Gu W, Pan F, Zhang H, et al. 2002. A predominantly nuclear protein affecting cytoplasmic localization of beta-actin mRNA in fibroblasts and neurons. J Cell Biol 156:41-51.
39. Hinton VJ, Brown WT, Wisniewski K, et al. 1991. Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet 41:289-294.
40. Huber KM, Gallagher SM, Warren ST, et al. 2002. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99:7746-7750.
41. Huttenlocher PR. 1974. Dendritic development in neocortex of children with mental defect and infantile spasms. Neurology 24:203-210.
42. Irwin SA, Swain RA, Christmon CA, et al. 2000. Evidence for altered fragile-X ment retard protein expression in response to behavioral stimulation. Neurobiol Learn Mem 73:87-93.
43. Irwin SA, Patel B, Idupulapati M, et al. 2001. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination. Am J Med Genet 98:161-167.
44. Ishizuka A, Siomi MC, Siomi H. 2002. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev 16:2497-2508.
45. Jiang C, Schuman EM. 2002. Regulation and function of local protein synthesis in neuronal dendrites. Trends Biochem Sci 27:506-513.
46. Kaufmann WE, Moser HW. 2000. Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex 10:981-991.
47. Kiebler MA, DesGroseillers L. 2000. Molecular insights into mRNA transport and local translation in the mammalian nervous system. Neuron 25:19-28.
48. Kleiman R, Banker G, Steward O. 1994. Development of subcellular mRNA compartmentation in hippocampal neurons in culture. J Neurosci 14:1130-1140.
49. Knowles RB, Sabry JH, Martone ME, et al. 1996. Translocation of RNA granules in living neurons. J Neurosci 16:7812-7820.
50. Kobayashi K, Kuroda S, Fukata M, et al. 1998. p140Sra-1 (specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase. J Biol Chem 273:291-295.
51. Kohrmann M, Luo M, Kaether C, et al. 1999. Microtubule-dependent recruitment of Staufen-green fluorescent protein into large RNA-containing granules and subsequent dendritic transport in living hippocampal neurons. Mol Biol Cell 10:2945-2953.
52. Laggerbauer B, Ostareck D, Keidel EM, et al. 2001. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet 10:329-338.
53. Latham VM, Yu EH, Tullio AN, et al. 2001. A Rho-dependent signaling pathway operating through myosin localizes beta-actin mRNA in fibroblasts. Curr Biol 11:1010-1016.
54. Lewis HA, Musunuru K, Jensen KB, et al. 2000. Sequence-specific RNA binding by a Nova KH domain: Implications for paraneoplastic disease and the fragile X syndrome. Cell 100:323-332.
55. Li Z, Zhang Y, Ku L, et al. 2001. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res 29:2276-2283.
56. Long RM, Gu W, Lorimer E, et al. 2000. She2p is a novel RNA-binding protein that recruits the Myo4p-She3p complex to ASH1 mRNA. EMBO J 19:6592-6601.
57. Luo L. 2000. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 1:173-180.
58. Luthi A, Di Paolo G, Cremona O, et al. 2001. Synaptojanin 1 contributes to maintaining the stability of GABAergic transmission in primary cultures of cortical neurons. J Neurosci 21:9101-9111.
59. Lyford GL, Yamagata K, Kaufmann WE, et al. 1995. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14:433-445.
60. Macdonald P. 2001. Diversity in translational regulation. Curr Opin Cell Biol 13:326-331.
61. Markesich DC, Gajewski KM, Nazimiec ME, et al. 2000. bicaudal encodes the Drosophila beta NAC homolog, a component of the ribosomal translational machinery. Development 127:559-572.
62. Mayford M, Baranes D, Podsypanina K, et al. 1996. The 3′-untranslated region of CaMKII alpha is a cis-acting signal for the localization and translation of mRNA in dendrites. Proc Natl Acad Sci USA 93:13250-13255.
63. Miyashiro K, Beckel-Mitchener A, Purk T, et al. 2003. Cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37:417-431.
64. Morales J, Hiesinger PR, Schroeder AJ, et al. 2002. Drosophila Fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron 34:961-972.
65. Musco G, Stier G, Joseph C, et al. 1996. Three-dimensional structure and stability of the KH domain: Molecular insights into the fragile X syndrome. Cell 85:237-245.
66. Muslimov IA, Santi E, Homel P, et al. 1997. RNA transport in dendrites: A cis-acting targeting element is contained within neuronal BC1 RNA. J Neurosci 17:4722-4733.
67. Nimchinsky EA, Oberlander AM, Svoboda K. 2001. Abnormal development of dendritic spines in fmr1 knock-out mice. J Neurosci 21:5139-5146.
68. Purpura RP. 1974. Dendritic spine dysgenesis and mental retardation. Science 186:1126-1128.
69. Rehbein M, Kindler S, Horke S, et al. 2000. Two trans-acting rat-brain proteins, MARTA1 and MARTA2, interact specifically with the dendritic targeting element in MAP2 mRNAs. Brain Res Mol Brain Res 79:192-201.
70. Rook MS, Lu M, Kosik KS. 2000. CaMKIIalpha 3′ untranslated region-directed mRNA translocation in living neurons: Visualization by GFP linkage. J Neurosci 20:6385-6393.
71. Rudelli RD, Brown WT, Wisniewski K, et al. 1985. Adult fragile X syndrome: Cliniconeuropathologic findings. Acta Neuropathol 67:289-295.
72. Schaeffer C, Bardoni B, Mandel JL, et al. 2001. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J 20:4803-4813.
73. Schenck A, Bardoni B, Moro A, et al. 2001. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc Natl Acad Sci USA 98:8844-8849.
74. Siomi H, Dreyfuss G. 1997. RNA-binding proteins as regulators of gene expression. Curr Opin Genet Dev 7:345-353.
75. Siomi H, Siomi MC, Nussbaum RL, et al. 1993. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74:291-298.
76. Siomi H, Choi M, Siomi MC, et al. 1994. Essential role for KH domains in RNA binding: Impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77:33-39.
77. Sittler A, Devys D, Weber C, et al. 1996. Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of FMR1 protein isoforms. Hum Mol Genet 5:95-102.
78. Snyder EM, Philpot BD, Huber KM, et al. 2001. Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat Neurosci 4:1079-1085.
79. Steward O. 2002. mRNA at synapses, synaptic plasticity, and memory consolidation. Neuron 36:338-340.
80. Steward O, Schuman EM. 2001. Protein synthesis at synaptic sites on dendrites. Annu Rev Neurosci 24:299-325.
81. Steward O, Worley PF. 2001. Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation. Neuron 30:227-240.
82. Steward O, Bakker CE, Willems PJ, et al. 1998a. No evidence for disruption of normal patterns of mRNA localization in dendrites or dendritic transport of recently synthesized mRNA in FMR1 knockout mice, a model for human fragile-X mental retardation syndrome. NeuroReport 9:477-481.
83. Steward O, Wallace CS, Lyford GL, et al. 1998b. Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron 21:741-751.
84. Stickeler E, Fraser SD, Honig A, et al. 2001. The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. EMBO J 20:3821-3830.
85. Sundell CL, Singer RH. 1991. Requirement of microfilaments in sorting of actin messenger RNA. Science 253:1275-1277.
86. Sung YJ, Dolzhanskaya N, Nolin SL, et al. 2003. The fragile X mental retardation protein FMRP binds elongation factor 1A mRNA and negatively regulates its' translation in vivo. J Biol Chem 278(18):15669-15678.
87. Takei Y, Teng J, Harada A, et al. 2000. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J Cell Biol 150:989-1000.
88. Takizawa PA, Vale RD. 2000. The myosin motor, Myo4p, binds Ash1 mRNA via the adapter protein, She3p. Proc Natl Acad Sci USA 97:5273-5278.
89. Tamanini F, Willemsen R, van Unen L, et al. 1997. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum Mol Genet 6:1315-1322.
90. Tang SJ, Meulemans D, Vazquez L, et al. 2001. A role for a rat homolog of staufen in the transport of RNA to neuronal dendrites. Neuron 32:463-475.
91. Todd PK, Mack KJ. 2000. Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo [In Process Citation]. Brain Res Mol Brain Res 80:17-25.
92. Togel M, Wiche G, Propst F. 1998. Novel features of the light chain of microtubule-associated protein MAP1B: Microtubule stabilization, self interaction, actin filament binding, and regulation by the heavy chain. J Cell Biol 143:695-707.
93. Verheij C, De Graaff E, Bakker CE, et al. 1995. Characterization of FMR1 proteins isolated from different tissues. Hum Mol Genet 4:895-901.
94. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
95. Wang H, Iacoangeli A, Popp S, et al. 2002. Dendritic BC1 RNA: Functional role in regulation of translation initiation. J Neurosci 22:10232-10241.
96. Weiler IJ, Irwin SA, Klintsova AY, et al. 1997. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94:5395-5400.
97. Willemsen R, Bontekoe C, Tamanini F, et al. 1996. Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem Biophys Res Comm 225:27-33.
98. Zalfa F, Giorgi M, Primerano B, et al. 2003. The fragile X syndrome protein FMRP regulates the translation of specific mRNAs at the synapses via BC1 RNA. Cell 112:317-327.
99. Zhang HL, Singer RH, Bassell GJ. 1999. Neurotrophin regulation of beta-actin mRNA and protein localization within growth cones. J Cell Biol 147:59-70.
100. Zhang HL, Eom T, Oleynikov Y, et al. 2001a. Neurotrophin-induced transport of a beta-actin mRNP complex increases beta-actin levels and stimulates growth cone motility. Neuron 31:261-275.
101. Zhang Y, Oconnor JP, Siomi MC, et al. 1995. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J 14:5358-5366.
102. Zhang YQ, Bailey AM, Matthies HJ, et al. 2001b. Drosophila Fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107:591-603.